Retinoblastoma Consolidation in Egyptians

Starting soon

Conditions studied: Retinoblastoma

In brief

This analysis will evaluate the investigators' institution's specific experience using Ru-106 isotopes, cryotherapy, or transpupillary thermotherapy (TTT) to treat persistent or recurrent RB in patients who previously underwent systemic IVC or IAC. The investigators aim to detail the demographics, clinical indications, success rates-specifically local control and globe salvage-, predictive factors for success, and complications of each modality of treatment within a tertiary eye care setting in Egypt.

Key facts

Study ID

NCT07530458

Run by

Assiut University

People needed

150

Starts

2026-05-01

Expected to finish

2027-06-01

Last updated by the study team

2026-04-15

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients receiving secondary consolidation therapy with at least one year of post-treatment follow-up.

You may not qualify if…

• Incomplete data, extraocular or orbital RB at initial presentation, or follow-up duration under one year.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.